美国 · 平台与数据 · MarketBeat
Milestone Pharmaceuticals (NASDAQ:MIST) Stock Rating Upgraded by Wall Street Zen

详细摘要
Wall Street Zen raised shares of Milestone Pharmaceuticals from a "strong sell" rating to a "sell" rating in a report on Saturday.
MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.marketbeat.com)



